Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

AFRICA: Brutal Practice Linked to AIDS


Toronto Star (09.01.07) - Monday, September 10, 2007

Women in sub-Saharan African who undergo female genital mutilation are increasingly at risk for HIV/AIDS, according to researchers and activists. Over the past 10 years, sporadic research data have linked FGM to rising rates of HIV transmission among women in countries where it is widely practiced.

"Because FGM is coupled with the loss of blood and use is often made of one instrument for a number of operations, the risk of HIV/AIDS transmission is increased by the practice. Also, due to damage to the female sex organs, sexual intercourse can result in lacerations of tissues, which greatly increases risk of transmission. The same is true for childbirth and subsequent loss of blood," said the UN Population Fund. Groups such as the London-based International Community of Women Living with HIV/AIDS and the Washington- based Global Health Council concur.

According to a cross-section of data from a 2006 UN report on AIDS, in countries where FGM is common - including Somalia, Sudan, Tanzania, and Djibouti - an estimated 55-60 percent of HIV infections are among women.

FGM is outlawed in most countries, though it continues to be practiced in 28 African nations and in parts of the Middle East and Asia, the World Health Organization reports. In total, more than 100 million girls have suffered FGM, with 3 million more undergoing it annually.

Of the three most-common forms of FGM, Type III, also known as infibulation or Pharaonic circumcision, is the most extreme. The procedure involves removing the clitoris and labia and stitching the vaginal opening shut, save for a small space for the passage of urine and menstrual blood. Type III is common in Somalia, Sudan, and Djibouti, where some 98 percent of women have suffered some form of FGM, reports Human Rights Watch.


Copyright © 2007 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in September 10, 2007. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.